Andere Sprachen Revvity, Inc.

Aktien

850943

US7140461093

RVTY

Medizinische Ausrüstung

Realtime-Estimate Cboe BZX Andere Börsenplätze 17:47:06 11.06.2026			% 5 Tage	Veränd. 1. Jan.
100,36 ^USD	-0,91 %		-2,29 %	+3,42 %

09.06.	Revvity, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 08:40 AM
13.05.	Revvity, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 09:20 AM

Andere Sprachen

13.05.	Revvity receives FDA clearance for total testosterone assay enabling comprehensive automated testosterone testing solution
08.05.	Revvity : First Quarter 2026 Transcript
05.05.	Revvity, Inc. Reports Earnings Results for the First Quarter Ended April 05, 2026
05.05.	Revvity Q1 Adjusted Earnings, Revenue Rise
05.05.	Revvity trims annual profit, sales forecast to exclude China immunodiagnostics unit
05.05.	Revvity: Q1 Earnings Snapshot
05.05.	Earnings Flash (RVTY) Revvity, Inc. Reports Q1 Revenue $711.1M, vs. FactSet Est of $704.2M
05.05.	Earnings Flash (RVTY) Revvity, Inc. Posts Q1 Adjusted EPS $1.04 per Share, vs. FactSet Est of $1.02
05.05.	(RVTY) Revvity Expects 2026 Adjusted EPS Range $5.20-$5.30, vs. FactSet Est of $5.39
05.05.	(RVTY) Revvity Expects 2026 Pro Forma Revenue Range $2.81B-$2.84B
05.05.	Revvity : First Quarter 2026 Non-GAAP Reconciliations
05.05.	Revvity Announces Financial Results for the First Quarter of 2026
05.05.	Revvity, Inc. Updates Earnings Guidance for the Full Year 2026
05.05.	An undisclosed buyer signed a letter of intent to acquire Immunodiagnostics business in China from Revvity, Inc. for up to $200 million.
01.05.	Declaration of Voting Results by Revvity, Inc
30.04.	Revvity Board Declares Quarterly Dividend
30.04.	Revvity, Inc. announces Quarterly dividend, payable on August 07, 2026
17.04.	Revvity Showcases Integrated Cancer Research Solutions at AACR Annual Meeting 2026
16.04.	Revvity to Present at Upcoming Investor Conferences
16.04.	Revvity, Inc. Showcases Integrated Cancer Research Solutions At AACR Annual Meeting 2026
13.04.	Revvity to Hold Earnings Call on Tuesday, May 5, 2026
10.04.	Revvity to Hold Earnings Call on Tuesday, May 5, 2026
09.04.	Revvity Inc Announces Signals Biodesign Cloud-Native Molecular Cloning Solution
09.04.	Revvity Launches Signals BioDesign Offering for Biologics Research Workflows
09.04.	Revvity Unveils its Signals BioDesign Offering to Advance Biologic Research Workflows